首页 | 本学科首页   官方微博 | 高级检索  
   检索      


A whole genome screen for HIV restriction factors
Authors:Li Liu  Nidia MM Oliveira  Kelly M Cheney  Corinna Pade  Hanna Dreja  Ann-Marie H Bergin  Viola Borgdorff  David H Beach  Cleo L Bishop  Matthias T Dittmar  Áine McKnight
Institution:1. Department of Immunotherapeutics, Tokyo Medical and Dental University, Tokyo, Japan
2. Department of Hematology, Imamura Bun-in Hospital, Kagoshima, Japan
3. Division of Hematology, Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan
9. Department of Hematology, Osaka Minami Medical Center, Osaka, Japan
4. Department of Molecular Medical Science, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan
5. Cancer Centre, University of the Ryukyus Hospital, Okinawa, Japan
6. Department of Hematology, National Kyushu Cancer Center, Fukuoka, Japan
7. Institute for Clinical Research, National Kyushu Cancer Center, Fukuoka, Japan
8. Laboratory of Tumor Cell Biology, Department of Medical Genome Science, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan
Abstract:

Background

Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in a small percentage of infected individuals. ATL is often associated with general immune suppression and an impaired HTLV-1-specific T-cell response, an important host defense system. We previously found that a small fraction of asymptomatic HTLV-1-carriers (AC) already showed impaired T-cell responses against the major target antigen, Tax. However, it is unclear whether the impaired HTLV-1 Tax-specific T-cell response in these individuals is an HTLV-1-specific phenomenon, or merely reflects general immune suppression. In this study, in order to characterize the impaired HTLV-1-specific T-cell response, we investigated the function of Tax-specific CD8+ T-cells in various clinical status of HTLV-1 infection.

Results

By using tetramers consisting of HLA-A*0201, -A*2402, or -A*1101, and corresponding Tax epitope peptides, we detected Tax-specific CD8+ T-cells in the peripheral blood from 87.0% of ACs (n = 20/23) and 100% of HAM/TSP patients (n = 18/18) tested. We also detected Tax-specific CD8+ T-cells in 38.1% of chronic type ATL (cATL) patients (n = 8/21), although its frequencies in peripheral blood CD8+ T cells were significantly lower than those of ACs or HAM/TSP patients. Tax-specific CD8+ T-cells detected in HAM/TSP patients proliferated well in culture and produced IFN-γ when stimulated with Tax peptides. However, such functions were severely impaired in the Tax-specific CD8+ T-cells detected in cATL patients. In ACs, the responses of Tax-specific CD8+ T-cells were retained in most cases. However, we found one AC sample whose Tax-specific CD8+ T-cells hardly produced IFN-γ, and failed to proliferate and express activation (CD69) and degranulation (CD107a) markers in response to Tax peptide. Importantly, the same AC sample contained cytomegalovirus (CMV) pp65-specific CD8+ T-cells that possessed functions upon CMV pp65 peptide stimulation. We further examined additional samples of two smoldering type ATL patients and found that they also showed dysfunctions of Tax-specific but not CMV-specific CD8+ T-cells.

Conclusions

These findings indicated that Tax-specific CD8+ T-cells were scarce and dysfunctional not only in ATL patients but also in a limited AC population, and that the dysfunction was selective for HTLV-1-specifc CD8+ T-cells in early stages.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号